Health: Optical News

Today is June 20, 2024. All times in Eastern Daylight Time.

GenSight Biologics Renegotiates Financial Obligations and Provides Operational Updates

06/20/2024 - 01:30 AM

BUSINESS WIRE
Europe Eyewear and Optical Retailers Rankings and Profiles Report 2024 Featuring Grandvision, Specsavers, Fielmann, Krys, Optic 2000, Alain Afflelou, Apollo, Boots, Hartlauer, Salmoiraghi & Vigano - ResearchAndMarkets.com

06/19/2024 - 10:31 AM

BUSINESS WIRE
Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001

06/19/2024 - 08:00 AM

BUSINESS WIRE
Aurion Biotech CEO Greg Kunst Named Ernst & Young 2024 Entrepreneur of the Year Mountain West Region

06/17/2024 - 01:09 PM

BUSINESS WIRE
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress

06/17/2024 - 07:00 AM

BUSINESS WIRE
Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock

06/14/2024 - 07:00 AM

BUSINESS WIRE
EyeCare Partners Strengthens Executive Leadership Team with New Appointments

06/13/2024 - 12:26 PM

BUSINESS WIRE
Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease

06/13/2024 - 07:00 AM

BUSINESS WIRE
Global Brain and Vision Research Nonprofit to Host Inaugural Concert for Cures Celebrating Science

06/12/2024 - 12:51 PM

BUSINESS WIRE
Fortress Announces £750 million Forward Flow Agreement to Support the Continued Growth of Tabeo, the UK’s Largest Provider of Retail Finance for Primary Care Providers

06/12/2024 - 10:32 AM

BUSINESS WIRE
Pennsylvania Employees Benefit Trust Fund (PEBTF) Enhances Health Benefits for Commonwealth of Pennsylvania Employees Enrolled in the PEBTF

06/12/2024 - 09:00 AM

BUSINESS WIRE
From the Eye to the Brain: World’s Top Scientists Gather in Rome to Discuss Future of Neurotrophins in Eye and Brain Research

06/11/2024 - 06:56 AM

BUSINESS WIRE
Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease

06/11/2024 - 06:00 AM

BUSINESS WIRE
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States

06/10/2024 - 07:00 AM

BUSINESS WIRE
NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American

06/07/2024 - 06:50 AM

BUSINESS WIRE
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06/06/2024 - 04:01 PM

BUSINESS WIRE
Melt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery

06/06/2024 - 08:00 AM

BUSINESS WIRE
Verséa Health, Inc. Acquires ISO 9001 Certification

06/06/2024 - 06:00 AM

BUSINESS WIRE
Mississippi Retina Associates: Revolutionizing Retinal Care

06/05/2024 - 03:38 PM

BUSINESS WIRE
STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

06/05/2024 - 07:00 AM

BUSINESS WIRE
Harrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension Study

06/05/2024 - 07:00 AM

BUSINESS WIRE
Heru Prime Diagnostic Platform Showcased at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting held in Seattle, Garnering Praise for Exceptional Diagnostic Performance

06/04/2024 - 09:00 AM

BUSINESS WIRE
National Vision Expands Access to Affordable Eye Care and Eyewear with Opening of 1,000th America’s Best Store

06/04/2024 - 08:30 AM

BUSINESS WIRE
Azura Ophthalmics Announces Enrollment of First Patient in Phase 3 Clinical Trial for AZR-MD-001 in Patients with Meibomian Gland Dysfunction (MGD)

06/04/2024 - 08:00 AM

BUSINESS WIRE
GenSight Biologics invité à présenter aux prochaines conférences médicales et réunions scientifiques

06/04/2024 - 01:30 AM

BUSINESS WIRE

1 2 3

Next »

Search